Colgate-Palmolive (NYSE:CL) Chairman Ian M. Cook Sells 19,500 Shares

Colgate-Palmolive (NYSE:CL) Chairman Ian M. Cook sold 19,500 shares of the stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $73.97, for a total value of $1,442,415.00. Following the sale, the chairman now owns 1,088,367 shares of the company’s stock, valued at approximately $80,506,506.99. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Shares of Colgate-Palmolive stock traded down $1.49 on Friday, hitting $70.80. The company’s stock had a trading volume of 117,744 shares, compared to its average volume of 2,697,233. The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.78 and a current ratio of 1.13. Colgate-Palmolive has a 1 year low of $57.41 and a 1 year high of $76.41. The firm has a fifty day moving average price of $72.68 and a 200-day moving average price of $70.84. The company has a market capitalization of $61.88 billion, a price-to-earnings ratio of 23.84, a price-to-earnings-growth ratio of 4.64 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, July 26th. The company reported $0.72 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.72. Colgate-Palmolive had a negative return on equity of 10,821.98% and a net margin of 14.77%. The firm had revenue of $3.87 billion during the quarter, compared to analyst estimates of $3.88 billion. During the same quarter in the previous year, the business earned $0.77 EPS. Colgate-Palmolive’s revenue for the quarter was down .5% compared to the same quarter last year. As a group, analysts forecast that Colgate-Palmolive will post 2.84 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Wednesday, October 23rd will be issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 2.43%. The ex-dividend date is Tuesday, October 22nd. Colgate-Palmolive’s dividend payout ratio is currently 57.91%.

Institutional investors have recently modified their holdings of the company. Dimensional Fund Advisors LP lifted its holdings in Colgate-Palmolive by 3.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,737,377 shares of the company’s stock valued at $103,412,000 after acquiring an additional 57,606 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Colgate-Palmolive by 7.9% in the fourth quarter. Geode Capital Management LLC now owns 10,540,277 shares of the company’s stock valued at $626,200,000 after acquiring an additional 768,550 shares during the last quarter. Brinker Capital Inc. acquired a new position in Colgate-Palmolive in the first quarter valued at approximately $207,000. Janus Henderson Group PLC lifted its stake in Colgate-Palmolive by 11.9% during the first quarter. Janus Henderson Group PLC now owns 453,173 shares of the company’s stock worth $31,058,000 after purchasing an additional 48,103 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado lifted its stake in Colgate-Palmolive by 4.1% during the first quarter. Public Employees Retirement Association of Colorado now owns 153,787 shares of the company’s stock worth $10,541,000 after purchasing an additional 6,061 shares in the last quarter. Institutional investors and hedge funds own 76.64% of the company’s stock.

A number of equities analysts recently commented on the company. Deutsche Bank increased their price target on Colgate-Palmolive from $74.00 to $76.00 and gave the company a “hold” rating in a research note on Friday, July 12th. UBS Group raised their price objective on Colgate-Palmolive from $80.00 to $82.00 and gave the company a “buy” rating in a research note on Monday, July 29th. ValuEngine downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $77.00 price target on the stock. in a report on Friday, June 7th. Finally, Morgan Stanley increased their price target on Colgate-Palmolive from $72.00 to $74.00 and gave the stock an “equal weight” rating in a report on Monday, July 29th. One analyst has rated the stock with a sell rating, twelve have given a hold rating and six have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $73.87.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

See Also: How can investors benefit from after-hours trading?

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.